FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113793313> ?p ?o ?g. }

• W2113793313 endingPage "163" @default.
• W2113793313 startingPage "156" @default.
• W2113793313 abstract "Context. Severe bleeding associated with dabigatran frequently requires intensive care management. An antidote is currently unavailable and data reporting the effect of dialysis on elimination of dabigatran are encouraging, but limited. Objective. To report the effect of intermittent hemodialysis (IHD) and continuous renal replacement therapy (CRRT) at enhancing elimination of dabigatran. Materials and methods. Patients were identified by existing collaborative networks. Pre-filter dabigatran plasma concentrations were measured in all patients, and in dialysate of three patients. Results. Seven patients received dialysis, five with active bleeding and two requiring emergent surgery. Five received IHD and two received CRRT. The plasma elimination half-life of dabigatran was 1.5–4.9 h during IHD, and 14.0–27.5 h during CRRT. Mean dabigatran plasma clearance during IHD was 85–169 mL/min in three patients. Time to obtain a subtherapeutic dabigatran concentration depended on the initial concentration, being 8–18 h for IHD in three patients while 4 h was insufficient in a supratherapeutic case. A 38% rebound in dabigatran levels occurred after one case during IHD, and thrombin time increased after IHD in another, but not after 144 h CRRT or 17 h IHD in two others; data were incomplete in three cases. The amount removed during IHD was proportional to the pre-IHD concentration and clearance, but was consistently low at 3.3–17.4 mg in three patients where this was determined. Moderate bleeding occurred while obtaining vascular access in one patient. Two patients died from intracerebral bleeding, and the influence of treatments could not be determined in these cases. Discussion and conclusions. IHD enhanced elimination of dabigatran more efficiently than CRRT, but their net effect remains poorly defined. Dialysis decisions, including modality and duration, must be individualized based on a risk–benefit assessment." @default.
• W2113793313 created "2016-06-24" @default.
• W2113793313 creator A5002845586 @default.
• W2113793313 creator A5023921089 @default.
• W2113793313 creator A5028312991 @default.
• W2113793313 creator A5037239474 @default.
• W2113793313 creator A5065087338 @default.
• W2113793313 creator A5072451471 @default.
• W2113793313 creator A5083099735 @default.
• W2113793313 creator A5085506663 @default.
• W2113793313 creator A5089722288 @default.
• W2113793313 creator A5037367546 @default.
• W2113793313 date "2015-02-08" @default.
• W2113793313 modified "2023-10-03" @default.
• W2113793313 title "Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran" @default.
• W2113793313 cites W1547546593 @default.
• W2113793313 cites W1587492601 @default.
• W2113793313 cites W1971941179 @default.
• W2113793313 cites W1981340953 @default.
• W2113793313 cites W1982179895 @default.
• W2113793313 cites W1990272483 @default.
• W2113793313 cites W2014256079 @default.
• W2113793313 cites W2018609108 @default.
• W2113793313 cites W2020088401 @default.
• W2113793313 cites W2021457977 @default.
• W2113793313 cites W2021808899 @default.
• W2113793313 cites W2031690663 @default.
• W2113793313 cites W2033430377 @default.
• W2113793313 cites W2045815862 @default.
• W2113793313 cites W2048199378 @default.
• W2113793313 cites W2062349400 @default.
• W2113793313 cites W2062946016 @default.
• W2113793313 cites W2073308951 @default.
• W2113793313 cites W2078040803 @default.
• W2113793313 cites W2081580861 @default.
• W2113793313 cites W2113446992 @default.
• W2113793313 cites W2119622751 @default.
• W2113793313 cites W2121519022 @default.
• W2113793313 cites W2124882231 @default.
• W2113793313 cites W2125957676 @default.
• W2113793313 cites W2136489990 @default.
• W2113793313 cites W2138047112 @default.
• W2113793313 cites W2142970733 @default.
• W2113793313 cites W2153419241 @default.
• W2113793313 cites W2160199160 @default.
• W2113793313 cites W2164905685 @default.
• W2113793313 cites W2169240174 @default.
• W2113793313 cites W2203036336 @default.
• W2113793313 cites W2314496365 @default.
• W2113793313 cites W26504394 @default.
• W2113793313 cites W81449517 @default.
• W2113793313 doi "https://doi.org/10.3109/15563650.2015.1004580" @default.
• W2113793313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25661675" @default.
• W2113793313 hasPublicationYear "2015" @default.
• W2113793313 type Work @default.
• W2113793313 sameAs 2113793313 @default.
• W2113793313 citedByCount "27" @default.
• W2113793313 countsByYear W21137933132015 @default.
• W2113793313 countsByYear W21137933132016 @default.
• W2113793313 countsByYear W21137933132017 @default.
• W2113793313 countsByYear W21137933132018 @default.
• W2113793313 countsByYear W21137933132019 @default.
• W2113793313 countsByYear W21137933132020 @default.
• W2113793313 crossrefType "journal-article" @default.
• W2113793313 hasAuthorship W2113793313A5002845586 @default.
• W2113793313 hasAuthorship W2113793313A5023921089 @default.
• W2113793313 hasAuthorship W2113793313A5028312991 @default.
• W2113793313 hasAuthorship W2113793313A5037239474 @default.
• W2113793313 hasAuthorship W2113793313A5037367546 @default.
• W2113793313 hasAuthorship W2113793313A5065087338 @default.
• W2113793313 hasAuthorship W2113793313A5072451471 @default.
• W2113793313 hasAuthorship W2113793313A5083099735 @default.
• W2113793313 hasAuthorship W2113793313A5085506663 @default.
• W2113793313 hasAuthorship W2113793313A5089722288 @default.
• W2113793313 hasConcept C126322002 @default.
• W2113793313 hasConcept C141071460 @default.
• W2113793313 hasConcept C151730666 @default.
• W2113793313 hasConcept C2776301958 @default.
• W2113793313 hasConcept C2778063415 @default.
• W2113793313 hasConcept C2778810321 @default.
• W2113793313 hasConcept C2779161974 @default.
• W2113793313 hasConcept C2779343474 @default.
• W2113793313 hasConcept C2779365888 @default.
• W2113793313 hasConcept C2779541074 @default.
• W2113793313 hasConcept C2779978075 @default.
• W2113793313 hasConcept C29730261 @default.
• W2113793313 hasConcept C42219234 @default.
• W2113793313 hasConcept C71924100 @default.
• W2113793313 hasConcept C86803240 @default.
• W2113793313 hasConceptScore W2113793313C126322002 @default.
• W2113793313 hasConceptScore W2113793313C141071460 @default.
• W2113793313 hasConceptScore W2113793313C151730666 @default.
• W2113793313 hasConceptScore W2113793313C2776301958 @default.
• W2113793313 hasConceptScore W2113793313C2778063415 @default.
• W2113793313 hasConceptScore W2113793313C2778810321 @default.
• W2113793313 hasConceptScore W2113793313C2779161974 @default.
• W2113793313 hasConceptScore W2113793313C2779343474 @default.
• W2113793313 hasConceptScore W2113793313C2779365888 @default.

• next